✦ LIBER ✦

Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagy

✍ Scribed by Ozpolat, Bulent

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined inhibitory effect of formestane

✍ Carla Cavaliere; Sara Corvigno; Mario Galgani; Gennaro Limite; Agostina Nardone; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

304 Clinical Significance of Stem Cell P

✍ J. Kang; G. Gong; H.J. Lee; Y.K. Bae; A. Lee; E.Y. Cho; J.S. Lee; K.S. Suh; D.W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P31 Monitoring phenotypical changes of b

✍ N. Dahl; R. Leth-Larsen; H. Ditzel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

OP9 Predictive value of CD24 and CD44 fo

✍ K. Horiguchi; M. Toi; S. Horiguchi; M. Sugimoto; Y. Naito; Y. Hayashi; T. Ueno; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Primary breast cancer patients with high

✍ James M. Reuben; Bang-Ning Lee; Hui Gao; Evan N. Cohen; Michel Mego; Antonio Gio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 618 KB

CD24−/low stem-like breast cancer marker

✍ Bensimon, J; Altmeyer-Morel, S; Benjelloun, H; Chevillard, S; Lebeau, J 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 769 KB